Profound Medical Corp (NAS:PROF)
$ 7.37 -0.13 (-1.73%) Market Cap: 177.29 Mil Enterprise Value: 146.48 Mil PE Ratio: 0 PB Ratio: 3.90 GF Score: 55/100

Profound Medical Corp at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:30PM GMT
Release Date Price: $14.88 (+5.46%)
Mike Sarcone
Jefferies - Analyst

All right. Thank you. I think we can start. My name is Mike Sarcone. I am an analyst on the medical supplies and devices team here at Jefferies.

For this session, we've got Profound Medical and from the company, we've got Arun Menawat, CEO and Rashed Dewan, CFO. Arun is going to kick it off with a presentation. And if we have some time at the end, we can open it up for Q&A. So gentlemen, thanks for joining us today and Arun, I'll pass it to you.

Arun Menawat
Profound Medical Corp. - CEO & Chairman of the Board

Thank you so much, Michael. I'm really delighted to be here. And I'm delighted to be talking about Profound. So our mission is really to move surgery from minimally invasive or robotic surgeries to the next level, which we think is in incision-free surgery. So, big task.

And ablation of prostate tissue is our first of those applications. And I'm going to talk exclusively about prostate disease. So it's the largest cancer among men after skin cancer. There are two treatments that are really the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot